Also on Trial Friend:Multiple Myeloma pageCompare treatmentsMatch Me
All 549 Multiple Myeloma trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionMost sites in Michigan, Illinois and MinnesotaRecruitingAges 40-75Alliance for Clinical Trials in Oncology616US sites
43 states - Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaMost sites in Ohio, Illinois and MichiganRecruitingPhase 3Ages 18+ECOG-ACRIN Cancer Research Group482US sites
44 states - Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentMost sites in Michigan, Illinois and MinnesotaRecruitingPhase 3SWOG Cancer Research Network388US sites
35 states - Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialMost sites in Wisconsin, Illinois and MichiganRecruitingPhase 3Ages 18+ECOG-ACRIN Cancer Research Group303US sites
33 states - TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerMost sites in California, Maine and WisconsinRecruitingPhase 2Ages 12+American Society of Clinical Oncology145US sites
28 states - A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Most sites in California, New York and FloridaRecruitingCenter for International Blood and Marrow Transplant Research111US sites
39 states - MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Most sites in Florida, California and TexasRecruitingPhase 3Ages 18+Pfizer92US sites
19 states - A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaMost sites in Ohio, New York and North CarolinaRecruitingPhase 3Ages 18+Janssen Research & Development65US sites
27 states - A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple MyelomaMost sites in New York, California and TexasRecruitingPhase 3Ages 18+Janssen Research & Development47US sites
24 states - Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTMost sites in New York, North Carolina and OhioRecruitingPhase 3Ages 18+AstraZeneca44US sites
23 states - A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).Most sites in New York, North Carolina and TexasRecruitingPhase 3Ages 18-130AstraZeneca43US sites
19 states - Integrated Cancer Repository for Cancer ResearchMost sites in Missouri, Nebraska and FloridaRecruitingAges 19-110University of Nebraska42US sites
18 states - A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaMost sites in California, New York and OhioRecruitingPhase 3Ages 18+Janssen Research & Development41US sites
29 states - Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaMost sites in Florida, New York and TexasRecruitingPhase 2Ages 18+Juno Therapeutics, Inc., a Bristol-Myers Squibb Company38US sites
26 states - A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)Most sites in North Carolina, New York and TexasRecruitingPhase 3Ages 18+AstraZeneca36US sites
21 states - A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantMost sites in Florida, Alabama and New YorkRecruitingPhase 3Ages 18+Pfizer34US sites
8 states - AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)Most sites in California, Florida and TexasRecruitingPhase 1/2Ages 18+AstraZeneca33US sites
19 states - Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First RelapseMost sites in Illinois, Montana and IdahoRecruitingPhase 2Ages 18+National Cancer Institute (NCI)33US sites
5 states - A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Most sites in Florida, Maryland and North CarolinaRecruitingPhase 1/2Ages 12+Sumitomo Pharma America30US sites
18 states - A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)Most sites in Texas, Florida and CaliforniaRecruitingPhase 3Ages 18+GlaxoSmithKline30US sites
19 states
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Multiple Myeloma trials in the US, and what stage they are in
Of the 273 Multiple Myeloma trials with a US site, 28 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 165 of them. Phase 4 studies of an already approved treatment make up 4. The remaining 76 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 84 of them, and universities, hospitals, foundations and government groups run 189. The sponsors with the most are Memorial Sloan Kettering Cancer Center (14), M.D. Anderson Cancer Center (12) and Mayo Clinic (11). The most recently listed one first appeared on ClinicalTrials.gov on November 12, 2026.
Multiple Myeloma trials in the US, state by state
Of the 273 Multiple Myeloma trials with a US site, 19 accept children under 18. Their open sites are in 47 states and Washington, DC, most often Texas, New York and California. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 41 states
US hospitals running the most Multiple Myeloma trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Multiple Myeloma.
- Memorial Sloan Kettering Cancer CenterNew York, New York20 trials
- Dana-Farber Cancer InstituteBoston, Massachusetts19 trials
- Beth Israel Deaconess Medical CenterBoston, Massachusetts14 trials
- Colorado Blood Cancer InstituteDenver, Colorado13 trials
- Washington University School of MedicineSt Louis, Missouri13 trials
- Dana Farber Cancer InstituteBoston, Massachusetts11 trials
- Massachusetts General HospitalBoston, Massachusetts11 trials
- University of Nebraska Medical CenterOmaha, Nebraska11 trials
- M D Anderson Cancer CenterHouston, Texas10 trials
- Mayo Clinic in RochesterRochester, Minnesota10 trials
Help getting to a Multiple Myeloma trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Corporate Angel Network
- Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
- American Cancer Society Hope Lodge
- Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Multiple Myeloma trial near you
Are there Multiple Myeloma clinical trials near me?
As of November 21, 2026, 549 Multiple Myeloma clinical trials are recruiting now and 157 are not yet recruiting. In the US, 273 of them have at least 1 open site, across 50 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Multiple Myeloma clinical trial sites?
Recruiting Multiple Myeloma trials list open sites in 50 states and Washington, DC. New York, California and Texas have the most, and the table on this page lists every state.
Are there Multiple Myeloma trials for children near me?
Of the 273 Multiple Myeloma trials with a US site, 19 accept children under 18. Their open sites are in 47 states and Washington, DC, most often Texas, New York and California. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Multiple Myeloma clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.
What if there is no Multiple Myeloma trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Multiple Myeloma trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Multiple Myeloma: Abecma (idecabtagene vicleucel), Blenrep (belantamab mafodotin-blmf), Carvykti (ciltacabtagene autoleucel), Darzalex (daratumumab), Elrexfio (elranatamab-bcmm), Empliciti (elotuzumab), Kyprolis (carfilzomib), Lynozyfic (linvoseltamab-gcpt) and 20 more on the disease page.
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 21, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.
